News Archive

Funding supports Return’s mission to automate and scale B2B sales insights, enabling a smarter and faster enterprise through “microconversions”

TEDCO portfolio company SkySquad spotlighted on WMAR ABC 2.

After a lifetime working in the family construction business, Joseph Leiva developed the TargetDocs platform to help general contractors with project workflow and document management. The Montgomery County company recently completed an $850K funding round, with investment from Maryland institutions.

Recently-appointed TEDCO Chief Investment Officer Jack Miner reflects on a visit to the Flight 93 Memorial in Pennsylvania, and one of the tech development agency’s core values.

TEDCO's Bill Bernard Mentors Recipients of the SU Student Entrepreneurship Competition

TEDCO Porfolio companies Burn Along, Sonavi Labs, and PGDx are recipients of Baltimore Business Journal's 2021 Best in Tech Awards.

Three TEDCO Portfolio companies - Catalyte, Blackpoint Cyber, and CarrTech LLC. - are recipients of Maryland Tech Council's 2021 Industry Awards Celebration.

Bringing VC and entrepreneurial experience to a leading role in the Maryland agency’s investment activity, Frank has emerged as one of the go-to leaders in the state’s startup funding landscape since joining TEDCO in 2018. Linda Singh served as interim executive director of state-backed tech

With two ventures under his belt, Collier leads investment round connections for local startups like NewConnec t and Bullfrog AI at TEDCO, which is Maryland’s state-backed technology development agency.

TEDCO's Managing Executive Director of the Maryland Innovation Initiative, Arti Santhanam, PhD, was recognized as one of The Daily Record's Top 100 Women.

In her role as the Executive Director of the Maryland Stem Cell Research Fund, Amritha oversees all MSCRF activities and six programs accelerating stem cell research, commercialization, and cures.

emocha to use funding to drive expansion of Digital Medication Adherence Services to health plans and health systems.

TEDCO CEO Troy LeMaile-Stovall shares his thoughts on the push for more CEOs of color.

Adaptive Phage Therapeutics (APT), a Gaithersburg, Md.-based clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, closed a $40.75m Series B funding.